Filing Details

Accession Number:
0001104659-11-048995
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-26 17:48:52
Reporting Period:
2011-08-25
Filing Date:
2011-08-26
Accepted Time:
2011-08-26 17:48:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
808722 M David Knott 485 Underhill Blvd
Ste 205
Syosset NY 11791-3419
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-08-25 19,600 $12.57 756,180 No 4 P Indirect By Knott Partners, L.P.
Common Stock Acquisiton 2011-08-25 5,800 $12.57 227,661 No 4 P Indirect By Shoshone Partners, L.P.
Common Stock Acquisiton 2011-08-25 2,500 $12.57 93,233 No 4 P Indirect By Mulsanne Partners, L.P.
Common Stock Acquisiton 2011-08-25 9,900 $12.57 386,384 No 4 P Indirect By Knott Partners Offshore Master Fund, L.P.
Common Stock Acquisiton 2011-08-25 17,200 $12.57 62,783 No 4 P Indirect By Managed Account D
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Knott Partners, L.P.
No 4 P Indirect By Shoshone Partners, L.P.
No 4 P Indirect By Mulsanne Partners, L.P.
No 4 P Indirect By Knott Partners Offshore Master Fund, L.P.
No 4 P Indirect By Managed Account D
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 28,300 Indirect By Managed Account E
Common Stock 1,666 Indirect By Managed Account C
Common Stock 50,705 Direct
Footnotes
  1. The price reported in Column 4 of Table 1 is a weighted average price. The aggregate number of shares represented in that column was purchased in two transactions: (a) 50,000 shares at $12.5496 and (b) 5,000 shares at $12.7265. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the SEC, upon request, full information regarding the number of shares per beneficial holder purchased at each separate price set forth in this Footnote 1 of this Form 4.
  2. The Reporting Person is the managing member of Knott Partners Management, LLC, which is (a) the sole general partner of Shoshone Partners, L.P., Knott Partners Offshore Master Fund, L.P. and Mulsanne Partners, L.P. and (b) the managing general partner of Knott Partners, L.P. The Reporting Person is also a general partner of Knott Partners, L.P.
  3. The Reporting Person is the sole director and the president of Dorset Management Corporation, which (a) provides investment management services to Knott Partners Offshore (SRI) Fund Limited and (b) separate institutional managed accounts (each, a "Managed Account").
  4. As a result of the Reporting Person's interests in Knott Partners Management, LLC and in Dorset Management Corporation, the Reporting Person has investment discretion and control of the securities in this entry. The Reporting Person may be deemed to beneficially own an indirect pecuniary interest in securities in this entry as a result of a performance related fee. Except with respect to Knott Partners, L.P., Knott Partners Offshore Master Fund, L.P., Shoshone Partners, L.P., and Mulsanne Partners, L.P., in which the Reporting Person owns a beneficial interest, the Reporting Person disclaims beneficial ownership therein except to the extent ultimately realized. Each of Knott Partners, L.P., Knott Partners Offshore Master Fund, L.P., Shoshone Partners, L.P., Mulsanne Partners, L.P., Knott Partners Offshore (SRI) Fund Limited, and each of the Managed Accounts disclaims beneficial ownership of securities reported as owned by any other party.